期刊文献+

血浆Obestatin在非肥胖人群不同糖耐量状态下的水平变化 被引量:2

Changes in plasma obestatin levels in non-obese people with different glucose tolerance
暂未订购
导出
摘要 目的探讨血浆Obestatin在不同糖耐量状态下的水平变化以及与代谢指标的相关性。方法将80例非肥胖人群根据口服葡萄糖耐量实验(OGTT)结果分为正常糖耐量组(NGT)、糖耐量异常组(IGT)和2型糖尿病组(DM),比较不同组间各代谢指标及空腹血浆Obestatin的差异。结果Obestatin在NGT组(3.55±0.57)μg/L与IGT组(3.17±0.24)μg/L及DM组(2.85±0.53)μg/L内呈递减趋势(P<0.01);Obestatin为胰岛素抵抗指数(HOMA-IR)的独立相关因素(P<0.01)。结论Obestatin可能参与胰岛素抵抗,与糖代谢密切相关。 Objective To investigate the plasma obestatin state at different levels of impaired glucose tolerance and the relevance between the plasma obestatin and the metabolic indicators. Methods 80 cases of non-obese groups according to oral glucose tolercance test(OGTr) group were divided into normal glucose tolerance (NGT), impaired glucose tolerance group (IGT)and type 2 diabetes group (DM), compared with different groups of various metabolic indicators and the differences in fasting plasma obestatin. Results Obestatin in the NGT group (3.55 ± 0. 57 ) μg/L and [GT group(3.17 ±0.24 ) p,g/L and the DM group ( 2.85 ±0.53 )μg/L decreased significantly ( P 〈 0.01 ) ; obestatin was the independent relevant factors of insulin resistance index(HOMA-IR) (P 〈 0. 01 ). Conclusion obestatin may be involved in insulin resistance ,and is closely related to glucose metabolism.
出处 《安徽医科大学学报》 CAS 北大核心 2009年第6期732-734,共3页 Acta Universitatis Medicinalis Anhui
基金 安徽省自然科学基金(编号:070413104)
关键词 胰岛素抗药性 葡糖耐药试验 insulin resistance glucose tolerance test
  • 相关文献

参考文献9

  • 1Zhang J V,Ren P G,Avsian-Kretchmer O, et al. Obestatin,a peptide encoded by the ghrelin gene,opposes ghrelin's effects on food intake [J]. Science,2005,310 (5750) :996 - 9.
  • 2Vicennati V, Genghini S, De Iasio R, et al. Circulating Obestatin levels and the ghrelin/obestatin ratio in obese women [J]. Eur J Endocrinol,2007,157 ( 3 ) :295 - 301.
  • 3Nakahara T, Harada T, Yasuhara D, et al. Plasma Obestatin con- centrations are negatively correlated with body mass index, insuliu resistance index, and plasma leptin concentrations in obesity and anorexia nervosa [ J ]. Boil Psychiatry ,2008,64 ( 3 ) : 252 - 5.
  • 4Zamrazilova H, Hainer V, Sedlockova D, et al. Plasma Obestatin levels in normal weight, obese and anorectic women [J]. Physiol. Res,2008,57( Suppl 1 ) :S49 -55.
  • 5Granata R, Settanni F, Gallo D, et al. Obestatin promotes survival of pancreatic beta -cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function [J]. Diabetes,2008,57 (4) :967 -79.
  • 6Qi X, Li L, Yang G, et al. Circulating Obestatin levels in normal subjects and in patients with impaired glucose regulation and type 2 diabetes mellitus [ J ]. Clin Endocrinol,2007,66 (4) :593 - 7.
  • 7Lippl F, Erdmann J, Liehter N, et al. Relation of plasma Obestatin levels to BMl,gender,age and insulin[J]. Horm Metab Res,2008, 40(11) :806 - 12.
  • 8Tang S Q, Jiang Q Y, Zhang Y L, et al. Obestatin: its physicochemical characteristics and physiological functions [ J ]. Peptides, 2008,29(4) :639 -45.
  • 9Guo Z F,Ren A J,Zheng X ,et al. Different responses of circulating ghrelin, obestatin levels to fasting, re-feeding and different food compositions,and their local expressions in rats [J]. Peptides, 2008,29(7):1247 -54.

同被引文献10

  • 1Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth - hormone - releasing acylated PePtide from stomach [ J ]. Nature, 1999, 402 (6762):656 -660.
  • 2Zhang JV, Ren PG, Avsian - Kretchmer O, et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake[J]. Science, 2005, 310 (5750):996 -999.
  • 3Ren A J, Guo ZF, Wang YK, et al. Inhibitory effect of Obestatin onglu- cose - induced insulin secretion in rats [ J ]. Bioehem Biophys Res Commun,2008,369 (3) : 969 - 972.
  • 4Dezaki K, Sane H, Yada T. Ghrelin is a physiological regulator of in- sulin release in pancreatic islets and glucose homeostasis[ J]. Pharma- col Ther,2008,118 ( 2 ) : 239 - 249.
  • 5McCowen KC, Maykel JA, Bistrian BR, et al. Circulating ghrelin concentrations are lowered by intravenous glucose or hyperinsulinemic euglycemic conditions in rodents [ J ]. J Endocrinol, 2002,175 : R7 - R11.
  • 6Qi X, Li L, Yang G, et al. Circulating Obestatin levels in normal subjects and in patients with impaired glucose regulation and type 2 diabetes mellitus [ J ]. Clinical Endocrinology, 2007,66 (4) : 593 - 597.
  • 7James R J, Drewett RF, Cheetham TD. Low cord ghrelin levels in term infants are associated with slow weight gain over the first 3 months of life [ J ]. J Clin Endocrinol Metab, 2004,898 : 3847 - 3850.
  • 8张征,邹大进,陈月,王淼,吴捷,郭志福.Obestatin抑制3T3-L1前脂肪细胞的增殖与分化[J].第二军医大学学报,2007,28(9):929-932. 被引量:12
  • 9赵翠平,康冬梅.糖尿病患者外周血中Obestatin、Ghrelin水平变化[J].中国临床保健杂志,2009,12(6):589-591. 被引量:8
  • 10戴淑玲,马丽,修霞,董红旗,卢莉萍.妊娠期糖尿病孕妇血浆Ghrelin水平与胰岛素抵抗的研究[J].中国妇幼保健,2010,25(33):4855-4857. 被引量:3

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部